FDA Adverse Event Malfunction Summary report: N

CALCIUM GEN. 2

MDR report key: 19763731 · Received July 17, 2024

Report

Report Number
1823260-2024-02062
Event Type
Malfunction
Date Received
July 17, 2024
Date of Event
May 30, 2024
Report Date
August 29, 2024
Manufacturer
ROCHE DIAGNOSTICS
Product Code
CHW
UDI-DI
04015630924936
PMA / PMN Number
K113521
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
UK
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

THE C702 MODULE SERIAL NUMBER WAS (B)(6).

Additional Manufacturer Narrative · 0

QC WAS ACCEPTABLE. BASED ON THE INFORMATION PROVIDED, THE CAUSE OF THE EVENT COULD NOT BE DETERMINED. THE INVESTIGATION DID NOT IDENTIFY A PRODUCT PROBLEM.

Additional Manufacturer Narrative · 0

THE CUSTOMER REPORTED THREE NEW QUESTIONABLE CALCIUM GEN. 2 (CA2) RESULTS. THE CUSTOMER WAS ABLE TO PROVIDE ONE PATIENT SAMPLE WITH DISCREPANT RESULTS: ON (B)(6) 2024: SAMPLE ID (B)(6) THE INITIAL RESULT WAS 2.28 MMOL/L. THE REPEAT RESULT WAS 3.72 MMOL/L.

Description of Event or Problem · 0

THERE WAS AN ALLEGATION OF DISCREPANT RESULTS FOR 13 PATIENT SAMPLES TESTED FOR CALCIUM GEN. 2 (CA2) ON A COBAS 8000 C 702 MODULE BETWEEN (B)(6) 2024. REFER TO THE ATTACHED DATA FOR THE PATIENT RESULTS.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
362912 CALCIUM GEN. 2 TITRIMETRIC WITH EDTA AND INDICATOR, CALCIUM CHW ROCHE DIAGNOSTICS ASKU 04015630924936

Patients

Seq Age Sex Outcome Treatment
1 NA Unknown